| Pharmaceutical active ingredients: |
| Ranitidine Hydrochloride |
| Available forms, composition and doses of Zantac: |
| Capsules; Oral; Ranitidine Hydrochloride 150 mgCapsules; Oral; Ranitidine Hydrochloride 300 mgGranule, Effervescent; Oral; Ranitidine Hydrochloride 150 mgInjectable; Injection; Ranitidine Hydrochloride 25 mg / mlSolution; Oral; Ranitidine Hydrochloride 15 mg / mlSyrup; Oral; Ranitidine Hydrochloride 15 mg / mlSyrup; Oral; Ranitidine Hydrochloride 25 mg / mlTablets, Effervescent; Oral; Ranitidine Hydrochloride 150 mgTablets, Effervescent; Oral; Ranitidine Hydrochloride 25 mgTablets, Effervescent; Oral; Ranitidine Hydrochloride 300 mgTablets, Effervescent; Oral; Ranitidine Hydrochloride 75 mgTablets, Film-Coated; Oral; Ranitidine Hydrochloride 150 mgTablets, Film-Coated; Oral; Ranitidine Hydrochloride 300 mgTablets; Oral; Ranitidine Hydrochloride 150 mgTablets; Oral; Ranitidine Hydrochloride 300 mgTablets; Oral; Ranitidine Hydrochloride 75 mg |
| Zantac medical category: |
| Human:Antacids, antireflux agents and antiulcerantsHistamine H2-antagonists |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A02BA02 - Ranitidine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKlineBoehringer IngelheimFirma Chun CheongHospiraOrtho McNeil PharmaceuticalsPfizerWarner LambertZuellig Pharma |
| Related documents and information about Zantac: |
| Zantac prescribing information (PDF)Zantac injection prescribing information (PDF) |